Get App Open
In App
News on WhatsApp
News on WhatsApp
Open App

Rallis India Ltd.

BSE: 500355 | NSE: RALLIS |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE613A01020 | SECTOR: Pesticides & Agrochemicals

BSE Live

Apr 20, 16:01
261.35 -7.45 (-2.77%)
Volume
AVERAGE VOLUME
5-Day
13,705
10-Day
15,424
30-Day
20,034
28,724
  • Prev. Close

    268.80

  • Open Price

    270.30

  • Bid Price (Qty.)

    261.35 (5)

  • Offer Price (Qty.)

    264.00 (18)

NSE Live

Apr 20, 15:58
261.37 -6.63 (-2.47%)
Volume
AVERAGE VOLUME
5-Day
577,738
10-Day
480,693
30-Day
381,610
992,904
  • Prev. Close

    268.00

  • Open Price

    268.45

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    261.37 (729)

Company History - Rallis India
YEAR                                              EVENTS
 1948 - The Company was incorporated on 23rd August, at Calcutta. 
 The
        Company manufacture and sell pharmaceuticals, super
 phosphate,
        fertiliser mixtures, pesticides, hydrosulphite of soda,
 electric
        fans, petrol fans, petrol engines and garments and also to
 trade
        in fertiliser, cotton, tanning materials, piece goods,
 textiles,
        crushed bones and marine products.  The Company had
 distribution
        arrangements for single and compound fertilisers, electric
 fans,
        stationary and portable machine tools, electrical appliances,
        power sprayers, pharmaceuticals, chemicals, and household
        products.  Rallis Brothers Ltd., was incorporated in West
 Bengal
        to carry on business in India.
 
      - 75,000 Pref. Shares and 92,095 No. of equity shares issued to
        Ralli Bros. Ltd.  405 No. of equity shares to director and
        signatories to Memorandum of Association.  1,32,500 No. of
 equity
        shares issued to Ralli Bros. Ltd. on consideration of assets
        taken over from them.
 
 1951 - 65,000 Pref. and 1,15,000 No. of equity shares (prem. Rs 15
 per
        share) offered for sale by Ralli Brothers, Ltd., to the
 Indian
        public.
 
 1958 - The Company acquired the enterprise of Teddington Chemical
        Factory (P) Ltd.
 
 1961 - Reddington Chemicals was merged with the Company.
 
 1971 - Effective from 1st January, the Company negotiated the
        acquisition of assets of James & Co., a proprietary concern
        engaged in the canning of food under trade name SIL.
 
 1972 - Tata Fison Industries, Ltd., was amalgamated with the Company
        with effect from 1st September.  The shareholders of Tata
 Fison
        were allotted 3 fully paid-up Equity shares against 4 fully
        paid-up Equity shares, and 3 fully paid-up Equity shares plus
 3
        fractional certificates representing one tenth Equity shares
        against eight, Rs 55 paid-up Equity shares.  The Company's
        subsidiary Rallifan, Ltd. was merged with it with effect from
        31st August, 1966.
 
 1973 - Since September, the Company became a subsidiary of Rallis
 India,
        Ltd.  This was amalgamated with the Company effective from
 30th
        June, 1987.
 
      - 93,000 No. of equity shares issued as fully paid-up to
        shareholders of Tata Fison Industries, Ltd. pursuant to the
        Scheme of Amalgamation.
 
 1976 - 63,600 Right Equity shares issued in prop. 1:3 at a premium
 of
        Rs 25 per share on 5th January.  31 Right Equity shares
        forfeited.  1,14,470 Bonus Equity shares issued in prop.
 3:10.
 
 1978 - The subsidiary Ralli Chemicals Ltd. was merged with the
 Company
        with effect from 1st September.
 
 1981 - With effect from 1st September, Whilfens (India), Ltd. was
        amalgamated with the Company.  The shareholders of Whilfens
 were
        allotted 18,473 No. of equity shares of the Company in the
        proportion of 1 Ralli share of Rs 100 each for every 6 No. of
        equity shares of Rs 10 each held in Whilfen.
 
      - 33,331 shares allotted to Financial Institutions as part
        conversion of their loans.  (8,333 to ICICI, 8,333 to UTI and
        8,332 to GIC and its subsidiaries) and 18,473 shares allotted
 to
        erstwhile shareholders of Whilfens (India) Ltd., which was
        amalgamated with the Company.
 
 1982 - The Company acquired 2,10,286 No. of equity shares of Rs 10
 each
        of Protein Products of India, Ltd. which was deemed a
 Government
        Company pursuant to Section 619 B of the Company's Act.  The
        Company along with its subsidiaries - W.T. Surin & Co., Ltd.,
        Ralli Machines Ltd., and Ralliwolf, Ltd. held 60% of the
 equity
        capital of Protein Products of India, Ltd (PPI).  Hence, PPI
        became a subsidiary of the company. 
 
 1983 - Protein Products of India, Ltd., which manufactures gelatine,
        ossein and di-calcium phosphate, was merged with the Company
 with
        effect from 1st September.  The merger became effective on
 17th
        March, 1986.
 
 1985 - 16,441 No. of equity shares allotted without payment in cash
 to
        the Protein Products of India, Ltd. on its merger with the
        Company.
 
 1986 - The Plants for the manufacture of two new pesticides were
        commissioned at Ankleshwar.
 
      - The Company issued 3,95,000 - 13.5% secured redeemable partly
        convertible debentures of Rs 500 each during the year.  Out
 of
        the total issue, 18,811 debentures were offered to the
 employees
        of the Company and the balance of 3,76,189 debentures were
        offered to the existing equity shareholders in the proportion
 of
        2 debentures to 3 equity shares held.  Out of the employees'
        quota, only 11,834 debentures were taken up while the offer
 for
        shareholders was over-subscribed.  Thus, a total of 3,88,023
        debentures were allotted on 1st May, 1987.
 
      - Pursuant to the terms of the issue of debentures, the
 Convertible
        portion of Rs 250 out of each debenture was compulsorily and
        automatically converted into 10 equity shares of Rs 10 each
 of
        the Company at a premium of Rs 15 per share effective from
 1st
        November, 1987.
 
      - The Non-convertible portion of Rs 250 out of each debenture
        bearing interest at 13.5% per annum would be redeemed on
 maturity
        on 30th April, 1997.
 
      - The Company cancelled its 75,000 - 6% preference shares of Rs
 100
        each on 1st June, and in lieu thereof allotted 75,000 - 15%
        non-convertible debentures of Rs 100 each to the erstwhile
        preference shareholders.
 
 1987 - A modern bulk drug plant was commissioned at Ankleshwar to
        manufacture new drugs.
 
      - Plans for the manufacture of three new pesticides were
        commissioned and implementation of a fully export-oriented
 basic
        chemical manufacturing facility was in progress.
 
      - Ralli Machines Ltd. (RML), a subsidiary of the Company was
        amalgamated with the Company with effect from 1st June.
 
 1988 - The Agrochemicals division launched four new products during
 the
        period.  The Research and Development centre of the
 agrochemicals
        division set up a comprehensive toxicological laboratory at
        Bangalore.
 
 1989 - The agro chemicals division completed and commissioned new
        facilities for the manufacture of Acephate and Cypermethrin. 
 New
        facilities were set up for export oriented fungicides and
        achieved a two-fold expansion of productions of Captafol.  In
        addition, a new facility for an intermediate required in the
        production of Fenvalerate was set up and commissioned.
 
      - 7,627 No. of Equity shares allotted without payment in cash
 to
        shareholders of Rallis Machines, Ltd., on its merger.
 
 1990 - With considerable expertise gained in the designing and
        commissioning of chemical plants, the agro chemicals division
        entered the field of project exports.
 
      - At the meeting held on 21st November, the Company decided to
        dispose of the Engineering undertakings as well as the
 Company's
        direct and indirect shareholders in the Engineering
 subsidiaries
        Ralli Wolf Ltd. and the Indian Standard Metal Co., Ltd.
 
 1991 - The Agro chemicals unit signed a turnkey contract with the
        National Petrochemical Company of Iran for a 2500 TPA/500
 TPA.
 
      - A new facility for parenterals was put into operation at
        Aurangabad.  The pharmaceutical division diversified into
        Ayurvedic products range.
 
      - In term of the orders of the High Courts at Mumbai and
 Ahmedabad
        dated 4.5.1991 and 13.5.1991, Accumax Ltd. was merged with
 the
        Company on 26.6.1991 with retrospective effect from 1.1.1988.
 
        As per the terms of the merger, 60,800 shares of Rs 10 each
 were
        allotted to the shareholders of Accumax, Ltd.
 
      - Ahura Consultants & Investments Ltd. (Ahura), a subsidiary of
        the Company was amalgamated with the Company with effect from
 1st
        April.
 
      - The Company offered 11,91,337 - 12.5% secured partly
 convertible
        debentures of Rs 160 each on Rights basis in the proportion 1
        debentures: 8 equity shares held (All were taken up).
 
      - Another 59,570-12.5% debentures were issued to the employees
 on
        an equitable basis (only 5,211 debentures taken up).  The
        unsubscribed portion of 54,359 debentures was allowed to
 lapse.
        Rs 80 of the face value of each debenture was to be converted
        into 2 equity shares of Rs 10 each at a premium of Rs 30 per
        share on the expiry of 6 months from the date of allotment of
        debentures.  Remaining Rs 80 of the face value of each
 debenture
        was to be redeemed at par on the expiry of 10 years from the
 date
        of allotment of debentures.
 
      - 23,93,096 shares allotted (prem. Rs 30 per share) on part
        conversion 12.5% partly convertible debentures on 19.2.1992.
 
 1992 - Tata Tea Ltd. (TTL) proposed to make an offer to the resident
        Indian equity shareholders of the Company to acquire upto
 24.99%
        of the existing equity share capital of the Company.       
 
 1993 - The Company proposed to enter real estate development
 business.
 
 1995 - The agrochemicals division performed well and the unit
 introduced
        a range of other agro products as an input-supply agency. 
 The
        performance of pharmaceutical division affected due to
        non-availability of Dextran products.  Production of fine
        chemicals was affected due to non-availability of raw
 materials
        such as hydrochlorine and, bones etc.
 
 1996 - The pharmaceutical division registered an impressive
 performance
        and new products were introduced.
 
      - 350,00,000 pref. shares allotted as private placement basis
 and
        they would be redeemed at the end of 3 years from the date of
        allotment i.e. on 28.2.2000 & 30.3.2000 with pvt. & call
 option
        at the end of 2 years.
 
 1997 - Three new high margin products introduced during the year
        contributed to the success of the division.  Gelatine
 business
        was affected.  The leather chemicals business introduced a
 new
        range of finishing chemicals in collaboration with a U.K.
        Company.  Further expansion was planned in collaboration with
 a
        Dutch company and with their support it was proposed to
 introduce
        a range of high quality fat liquors.
 
      - British drug group Phytopharm Plc said on November 3 it had
        signed a long-term agreement with Rallis India Ltd to develop
        products based on medicinal plant extracts.
 
      - Rallis is part of India's Tata Group, the country's largest
        business conglomerate.
 
      - Rallis is the largest agro-business company and the second
        largest seed producer in India.
 
      - Rallies has successfully introduced quality hybrid seeds in
        collaboration with Cargill Seeds of USA and Bejo Zaden,
 Holland.
 
 1998 - Rallis India has forged a marketing alliance with the world's
        largest producer of fertilisers, Norsk Hydro of Netherlands,
 to
        market speciality fertilisers.
 
      - ICRA has assigned an `A1+' rating to the Rs.10 crore
 commercial
        paper programme of Rallis (India) Ltd (RIL).  The rating
        indicates highest safety.
 
      - The company has recently entered into separate licencing
        agreements with Switzerland-based pharma company Geisltch,
 and
        Netherlands-based Euro Drug.
 
      - The company has proposed to convert one of its existing
 pesticide
        units for producing special grade polymers for fabricating
        interiors of aircraft.
 
      - Rallis has also become the first Indian company to isolate a
        gene construct which marks the company's entry into the
 realms
        of genetically-engineered plants.
 
      - Rallis has also recently become only the second producer in
 the
        world, and the first in India, of pendimethylene, the world's
        number two herbicide.
 
      - The company has developed a 600 acre farm near Nashik in
        Maharashtra with technical collaboration from Mitsubishi
        Corporation of Japan.
 
 1999 - The company has been working closely with sericulturists and
        farmers in an attempt to develop the venture.  The company is
        also introducing international irrigation and sericulture
        techniques to improve yields, and productivity.
 
      - Tata group agrochemical major Rallis India has set up a new
        company called Rallis Farm Management to provide advisory and
        technical services in the agri sector.
 
      - Rallis had recently set up a new company -- called Rallis
 Farm
        Management -- to provide advisory and technical services in
 the
        agricultural sector.
 
      - Rallis India Ltd. and American multinational Monsanto have
 signed
        a memorandum of understanding (MoU) to jointly develop and
 launch
        rural-development initiatives in India.
 
      - Rallis India has entered into a pact with the $4.5bn FMC Ltd,
        the fifth-largest agrochemical producer in the world, under
        which it will formulate some of FMC's products in India. The
        agreement, signed on August 6, extends a relationship which
        Rallis already has with FMC for a few other products.
 
      - The rating agency, Icra, has downgraded the rating assigned
 to
        the Rs 5 crore non-convertible debenture (NCD) programme of
        Mold-Tek Plastics Ltd (MPL) from `LA+' to `LBBB+' indicating
        moderate safety.
 
 2000 
 
 - Tata Metaliks managing director Rajeev Dubey will take charge as
              chief executive officer of the Rs 1,256-crore Rallis
 India.
 
 - Tata group company, has decided to pull out of its agrochemical
 joint venture with FMC Corporation citing restructuring within the
 overall Tata group and recent changes in the global agrochemical
 market.
 
 -Rallis India, country's largest agrichemicals company, has tied up
 with the UK-based fertiliser giant Borax Europe to market Solubor in
 India in line with the company's strategy to market foreign companies
 products.
 
 -Launching an interactive Website called rallikisan.com
 
 -Sanat Products Limited (SPL)  in which Dabur India holds 30 per cent
 equity stake  has signed a marketing tie-up with the Tata group
 company Rallis India for distribution of its herbal OTC
 (over-the-counter) products in Africa and Sri Lanka.
 
 -Obtained a sanction for a Rs 50-crore term loan from ICICI Ltd
 
 2001 
 
 -Mr. R Gopalakrishnan, a director of Rallis India, has been appointed
 its vice-chairman. Gopalakrishnan is an executive director of Tata
 Sons and is a member of the group executive office of the Tata
 Group.
 
 -Sells its pharmaceutical business to Shreya Impex, part of
 Moscow-based Shreya Corporation, for Rs 49 crore.
 
 -Approves the merger of its wholly-owned subsidiaries with the
 company. The subsidiaries are Ralchem Ltd, Rallis Finance &
 Investments Co Ltd,
 
 -Kicks off a downsizing exercise for reducing employees at the
 managerial level. Around 200-odd managers opt for an early separation
 scheme started by the company in April 15, 2001
 
 -Fire breaks out at the Rallis Ankleshwar Plant Unit II. Seven
 workers sustain burn injuries.  Leakage of inflammable gas from a
 fractioning column of a unit manufacturing intermediate chemical CMAC
 used for manufacture of Cypermethrin, appeared to be the cause of the
 fire.
 
 -Launched its Web site, called www.rallis.co.in
 
 -Sells its surplus land at Andheri, a Mumbai suburb, to Tata
 Consultancy Services (TCS) for Rs 133 crore
 
 -Approves merger of its wholly owned subsidiaries i.e. Rallis Finance
 and Investments Ltd., Rallis Farm Management Services Ltd., Rallis
 Hybrid Seeds Ltd., Ralchem Ltd. and Sankhya Garments Ltd with the
 company.
 
 2002
 
 -Closes down four of its manufacturing units.The shut down four
 companies are Siris India's unit (a loss making subsidiary of Rallis
 India), Ralchem Ltd's second unit in Ankleshwar, a tanning and an
 agrochemicals unit at Ankleshwar.
 
 -Enters into a new contract farming agreement with State Bank of
 India, ending its earlier agreement with ICICI Bank
 
 -Mr. Rajeev Dubey, CEO & Executive Director of the company,
 redesignated as Managing Director w.e.f.July 29, 2002
 
 -Tata Chemicals Ltd. issues termination notice to the company in
 respect of the marketing arrangement for urea
 
 -Shareholders approve the Scheme of Amalgamation of its 5
 subsidiaries (Rallis Finance and Investments Company Ltd., Rallis
 Farm Management Services Ltd, Rallis Hybrid Seeds Ltd, Ralchem Ltd
 and Sankhya Garments Ltd with the Company)
 
 2003
 
 - Forges an alliance with Kureha Chemical Ltd, a leading Japanese
 company, for Metconazole fungicide plant
 
 -Approves the merger of Siris India Ltd., a wholly owned subsidiary
 of the company, with Rallis India Ltd.
 
 -Mr. Rajeev Dubey resigs as Managing Director
 
 -Dr. Venkatrao Sohoni appointed as Managing Director of the company
 w.e.f. August 11, 2003.
 
 -Offers VRS to its staff
 
 -Mrs. Shirin V. Balsara has resigned as Director (Legal) & Company
 Secretary of the Company w.e.f. September 20, 2003
 
 -Aproves the sale of Rallis House to Tata Consultancy Services Ltd
 for a total consideration of Rs 560 million
 
 -The Lok Prakashan Ltd. acquires 6,68,396 equity shares (constituting
 5.58% of the paid-up equity share capital of the Company)
 
 -Registered office of the company changed from Ralli House, 21,
 D.S.Marg, Mumbai - 400 001 to 7th Floor, Apeejay House, 3, Dinshaw
 Vachha Road, Churchgate, Mumbai 400 020. 
 
 2004
 
 -Board of the company decides to issue, on a private placement basis,
 9,00,00,000, 7.5 % Cumulative Redeemable Preference Shares of Rs 10/-
 each, aggregating to Rs 900 million. The said issue shall open from
 January 2, 2004 to January 31, 2004
 
 -Rallis India sells gelatine biz to Sterling Biotech Ltd
 
 -Rallis India inks pact with Dupont India Pvt Ltd on April 5, 2004,
 for insecticide marketing
 
 -Rallis India Ltd has informed that the company and EI Dupont India
 Private Ltd on April 5, 2004 have entered into an agreement, whereby
 company will co-market Dupont's insecticide Indoxacarb and Dupont
 will co-market company's insecticide Acetamiprid.
 
 - Rallis India enters into marketing alliances with global players
 like Syngenta, Bayer and Dupont
 
 2007
 
 -Rallis India Ltd has appointed Mr. Veeramani Shankar as the
 Executive Director of the Company.
 
 2008
 
 - Rallis India Ltd has informed that Dr. V S Sohoni has been
 appointed as Additional Director on the Board of the Company with
 effect from March 01, 2008.
 
 2009
 
 - Rallis India Ltd has appointed Mr. R. Mukundan as Additional
 Director on the Board of the Company.
 
 --Registered Office of the Company has been shifted to 156/157, 15th
 Floor, Nariman Bhavan, 227, Nariman Point, Mumbai - 400 021
 
 2010
 
 - Company has inaugurated a new Metconazole plant at its factory in
 Ankleshwar, Gujarat
 
 - Rallis India Ltd Acquires Majority stake in Metahelix Life
 Sciences
 
 - Rallis India - Board approves Bonus Issue
 
 -Rallis India has given the Bonus in the Ratio of 1:2
 
 2011
 
 -  Rallis India crosses sales figure of Rs 1,000 crore For the year
 ended March 31, 2011
 
 - Company has commenced commercial production at its new
 manufacturing facility at Dahej SEZ, Gujarat.
 
 -Company has splits its Face value of Shares from Rs 10 to Re 1
 
 2012
 
 - Rallis India Acquires 22.8% Stake in Zero Waste Agro Organics
 Private Limited
 
 2013
 
 - Tata Quality Management Services awarded Company's Dahej unit under
 Promising Innovations Category for New Product Innovation
 
 - The Company received National Energy Conservation Award from Mr.
 Pranab Mukerjee (President of India) for winning under Chemical
 sector
 
 -The Company awarded as Winner of Golden Peacock Award for
 Eco-Innovation in Chemical Sector
 
 - Federation of Indian Chambers of Commerce & Industry (FICCI)
 awarded the Company as Product Innovator of the Year in Agro Sector
 
 -The Company has recommended final dividend of Rs. 1.30 per share
 (130%) to the shareholders of the Company.
 
 2014
 
 - Rallis India Ltd appointed Dr. Punita Kumar-Sinha  as an Additional
 Non - Executive, Independent Director of the Company
 
 - The Company has recommended final dividend of Rs. 1.40 per share
 (140%) to the shareholders of the Company.
 
 
 - ICC awarded Certificate of Merit for Best Compliant Company for the
 Process Safety Code under Responsible Care
 
 - Dahej unit awarded National Safety Award
 
 - The Award was presented by Hon’ble Union Minister for Labour &
 Employment Shri Narendra Singh Tomar at Vigyan Bhavan, New Delhi
 
 2015
 -India's Most Trusted Brand Award, 2015 in Best Company category
 -CII EXIM prize for Business Excellence
 -Origin product has received Product Innovator of the Year in
 Agrochemicals Sector awarded by FICCI Chemicals & Petrochemicals
 Awards
 
 2016
 -Rallis India gets approval for Rs 200 cr project in Gujarat.        
                                                  
 -The Company has  signed an Agreement for increasing its stake in its
 Subsidiary Zero Waste Agro - Organics Limited from 73.63% to 100%.
 Consequently, ZWAO and  become a wholly owned subsidiary of the
 Company, on completion of the acquisition of the balance shares in
 ZWAOL.
 
 2019
 
 -The Company  has considered and approved the proposal for the merger
 of Metahelix Life Sciences Limited (''Transferor Company''), a wholly
 owned subsidiary of the Company, with Rallis India Limited (''the
 Company'' or ''Transferee Company'') and their Shareholders and
 Creditors, under Sections 230 to 234 of the Companies Act, 2013 
 
 
 2023
 -Rallis India powers its hybrid seed production process with mobile
 app  SeedSure.
 
 
 
 

Advisory Alert:

It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347